Quick Takeaways
- INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO).
- Disclosed ownership: 5.8%.
- Date of event: 22 Apr 2025.
INTEGRATED CORE STRATEGIES (US) LLC - 22 Apr 2025 SCHEDULE 13G Report for Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO)
- Filing Manager
- INTEGRATED CORE STRATEGIES (US) LLC
- Reporting Manager
- Integrated Core Strategies (US) LLC
- Symbol
- LXEO
- Shares outstanding
- 33,334,121 shares
- Disclosed Ownership
- 1,933,379 shares
- Ownership
- 5.8%
- Form type
- SCHEDULE 13G
- Filing time
- 28 Apr 2025, 16:03:16 UTC
- Date of event
- 22 Apr 2025
- Next filing
- 07 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"INTEGRATED CORE STRATEGIES (US) LLC disclosed 5.8% ownership in Lexeo Therapeutics, Inc. Common Stock, par value $0.0001 per share (LXEO) on 22 Apr 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 28 Apr 2025, 16:03.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 5.8% | 1,933,379 | 0 | 1,933,379 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 5.8% | 1,933,379 | 0 | 1,933,379 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 5.8% | 1,933,379 | 0 | 1,933,379 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 5.8% | 1,933,379 | 0 | 1,933,379 | /s/ Israel A. Englander | Israel A. Englander |